AAIC 2026: Tau-targeted Alzheimer’s treatments heat up while amyloid therapies persist

The lineup at the Alzheimer’s Association International Conference will provide critical insight into where the industry is headed with regard to targets being explored to vanquish the elusive neurodegenerative disease.

Scroll to Top